Importantly, LIPTER overexpression mitigates cardiomyopathies and preserves cardiac functions in mouse models of obesity and diabetes, highlighting LIPTER’s potential clinical relevance in treating human metabolic syndrome-associated heart disease and failure. Here, LINC00881 is linked to obesity due to melanocortin 4 receptor deficiency.